TECH Wichtige Statistiken
Hoch
72.12
Öffnen
71.60
Volumen
3.07M
Niedrig
71.50
Vorheriger Schlusskurs
71.77
Handelswert
221.03M
52W-Hoch
72.16
Rel. Volumen
0.367
Amplitude (%)
0.86%
52W-Tief
43.20
Umsatzrate
1.96%
Marktkapitalisierung
11.18B
KGV (TTM)
103.59
KGV (Jährlich)
153.447
KBV
5.39
KUV
9.28
Gewinn je Aktie (EPS)
0.696
Dividende (TTM)
0.317
Dividendenrendite
0.45%
Ausstehende Aktien
156.56M
Währung
USD
TECH Preis-Performance
7 Tag
30 Tag
90 Tag
180 Tag
Seit Jahresbeginn
1 Jahr
TECH Moneyflow-Verteilung
TECH Tägliches Leerverkaufsvolumen
TECH Short-Interest-Historie
TECH Aktien-Snapshot
As of 2026-07-18, the Bio-Techne Corp (TECH) stock price today is 72.12. Based on this price, the company has a market capitalization of $11.18B, with a P/E ratio of 103.59.
On 2026-07-18, TECH traded between 71.50 and 72.12. Today’s stock price is 0.87% above the daily low and 0.00% below the daily high, placing TECH nahe dem oberen Ende von its most recent trading range.
Trading volume currently stands at 3.07M, compared with an average daily volume of 8.38M. This suggests that trading activity is deutlich unter dem üblichen Niveau than usual.
Over the past year, Bio-Techne Corp shares have traded between 43.20 and 72.16. At today’s price, TECH is 66.94% above its 52-week low and 0.06% below its 52-week high.
TECH Verwandte Nachrichten
Über TECH
Firmenname
Bio-Techne Corp
Sektor
Health Technology
Branche
Biotechnology
Börsen
Nasdaq
Anzahl der Beschäftigten
3,100
Losgröße
100
Offizielle Website
Währung
USD
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Related Stocks
© 2026 CoinGlass, all rights reserved
